Molecular Diagnostic Reagent

Kaira™ COVID-19 Variants Detection Kit

The Kaira™ COVID-19 Variant Detection Kit is an in vitro diagnostic kit designed for the qualitative detection of SARS-CoV-2(RdRP gene and/or ORF1a gene), and 7 Variants SNP(N501Y, D614G, W152C, K417T/N, L452R, E484K/Q, P681H/R) in human upper respiratory (oropharyngeal/nasopharyngeal swab), saliva and nasal swap specimens through real-time reverse transcription polymerase chain reaction (real-time RT-PCR).
Also,The Kaira™ COVID-19 Variant Detection Kit has PCRC which helps to monitor the RNA extraction and PCR process.

Features

  • Detection of SARS-CoV-2 target genes (RdRP and E gene)
  • Detection of SARS-CoV-2 S gene variant SNP (N501Y, D614G, W152C, K417T/N, L452R, E484K/Q, P681H/R)
  • Ready to use kit including Positive Control
  • Compatible with Bio-Rad CFX96 RT-PCR system
  • Compatible with various commercial extraction system
  • Store at -25 ~ – 15℃ (-13 ~ 5℉)

Product Components

  • COVID Variant Primer & probe mixture A 2ea
  • COVID Variant Primer & probe mixture B 2ea
  • 2X OneStep RT qPCR mixture 4ea
  • COVID Variant Positive control DNA A 1ea
  • COVID Variant Positive control DNA B 1ea
  • DEPC treated D.W. 1ea

Certificate

No (Research Use Only)

Cat. No

RDM105-X-R

Kaira™ COVID-19/Flu detection kit

In vitro diagnostic kit designed for the qualitative detection of SARS-CoV-2(RdRP gene, E gene), Influenza A(InF A) and Influenza B(InF B) in human samples such as oropharyngeal/nasopharyngeal swab, nasopharyngeal swab and sputum through reverse transcription real-time polymerase chain reaction (RT-qPCR).
For professional use only.

Features

  • Detection of SARS-CoV-2 target genes (RdRP and E gene)
  • Detection of Influenza A, Influenza B
  • Ready to use kit including Positive Control
  • Compatible with Bio-Rad CFX96 RT-PCR system
  • Compatible with various commercial extraction system
  • Store at -25 ~ – 15℃ (-13 ~ 5℉)

Product Components

  • Primer & Probe mixture (COVID/Flu) 2ea
  • 2X OneStep RT-qPCR mixture 2ea
  • Positive control DNA 1ea
  • DEPC treated D.W. 1ea

Certificate

  • KMFDS
  • CE-IVD

Cat. No

RDM103-X

Kaira 2019-nCoV Detection Kit(RDM101-X)

In vitro diagnostic kit designed for the qualitative detection of SARS-CoV-2(RdRP gene, E gene) in human samples such as oropharyngeal/nasopharyngeal swab and sputum through reverse transcription real-time polymerase chain reaction (RT-qPCR).
For professional use only.

Features

  • Detection of SARS-CoV-2 target genes (RdRP and E gene)
  • Ready to use kit including Positive Control
  • Compatible with various real-time PCR system
    (Bio-Rad CFX96, ABI 7500, Thermo Fisher Scientific QS5)
  • Compatible with various commercial extraction system
  • Store at -25 ~ – 15℃ (-13 ~ 5℉)

Product Components

  • 2019-nCoV Primer & Probe Mixture 2ea
  • 2X OneStep RT qPCR Mixture 2ea
  • 2019-nCoV Positive control DNA 1ea
  • DEPC treated D.W. 1ea

Certificate

  • KMFDS
  • CE-IVD
  • FDA EUA
  • HAS (Singapore)
  • COFEPRIS (Mexico)
  • CDSCO (India)
  • MOH (Indonesia)

Cat. No

RDM101-X

© 2020 OPTOLANE Technologies Inc. All rights reserved.